Citations

Mayo Clinic

Showing 10 of 108599 citations.

Sex Differences in Bicuspid Aortic Valve Adults
Mankad, Sunil , Mankad, Sunil V., Michelena, Héctor I.

Circulation: Cardiovascular Imaging | March 2, 2017 | Volume: 10 | Issue: 3 | Pages: No page available

10.1161/circimaging.117.006123 | PMID 28251912 Get It

Consensus classification of posterior cortical atrophy
Crutch, Sebastian J. , Schott, Jonathan M. , Rabinovici, Gil D. , Murray, Melissa E. , Flier, Wiesje M. van der , Vandenberghe, Rik , Ahmed, Samrah , Bak, Thomas H. , Boeve, Bradley F., Butler, Christopher , Cappa, Stefano F. , Ceccaldi, Mathieu, Souza, Leonardo Cruz de , Dubois, Bruno, Félician, Olivier , Graff‐Radford, Jonathan , Graff‐Radford, Neill R. , Hof, Patrick R., Krolak‐Salmon, Pierre , Lehmann, Manja , Magnin, Éloi , Mendez, Mario F. , Nestor, Peter J. , Onyike, Chiadi U. , Pelak, Victoria S. , Pijnenburg, Yolande A.L. , Primativo, Silvia , Rossor, Martin N. , Ryan, Natalie S. , Scheltens, Philip , González, Aida Suárez, Tang‐Wai, David F. , Yong, Keir , Carrillo, María C. , Fox, Nick C. , Murray, Melissa, Snowden, Julie S. , Dickerson, Bradford Clark , Boeve, Bradley F. , Galasko, Douglas , Hof, Patrick R. , Shakespeare, Timothy J. , Gonzalez, Aida Suarez , Murray, Melissa E , van der Flier, Wiesje M , Scheltens, Philip , Fox, Nick C , Yong, Keir X X , Rabinovici, Gil D , Schott, Jonathan M , Pijnenburg, Yolande A L , Vandenberghe, Rik

Alzheimer's & Dementia | March 2, 2017 | Volume: 13 | Issue: 8 | Pages: 870-884

10.1016/j.jalz.2017.01.014 | PMID 28259709 Get It

Abstract Introduction A classification framework for posterior cortical atrophy (PCA) is proposed to improve the uniformity of definition of the syndrome in a variety of research settings. Methods Consensus statements about PCA were developed through a detailed literature review, the formation of an international multidisciplinary working party which convened on four occasions, and a Web‐based quantitative survey regarding symptom frequency and the conceptualization of PCA. Results A three‐level classification framework for PCA is described comprising both syndrome‐ and disease‐level descriptions. Classification level 1 (PCA) defines the core clinical, cognitive, and neuroimaging features and exclusion criteria of the clinico‐radiological syndrome. Classification level 2 (PCA‐pure, PCA‐plus) establishes whether, in addition to the core PCA syndrome, the core features of any other neurodegenerative syndromes are present. Classification level 3 (PCA attributable to AD [PCA‐AD], Lewy body disease [PCA‐LBD], corticobasal degeneration [PCA‐CBD], prion disease [PCA‐prion]) provides a more formal determination of the underlying cause of the PCA syndrome, based on available pathophysiological biomarker evidence. The issue of additional syndrome‐level descriptors is discussed in relation to the challenges of defining stages of syndrome severity and characterizing phenotypic heterogeneity within the PCA spectrum. Discussion There was strong agreement regarding the definition of the core clinico‐radiological syndrome, meaning that the current consensus statement should be regarded as a refinement, development, and extension of previous single‐center PCA criteria rather than any wholesale alteration or redescription of the syndrome. The framework and terminology may facilitate the interpretation of research data across studies, be applicable across a broad range of research scenarios (e.g., behavioral interventions, pharmacological trials), and provide a foundation for future collaborative work.
Preventing cardiovascular disease: Participant perspectives of the FAITH! Program
Dean, Patrick J., Lackore, Kandace A. , Jenkins, Sarah M. , Cohen, Consuelo, Johnson, Jacqueline , Ellis, Frances, Mangum, DC, Brewer, LaPrincess C. , Morrison, Eleshia J, Balls-Berry, Joyce E, Lackore, Kandace, Morrison, Eleshia J. P. , Balls‐Berry, Joyce E. , Hayes, Sharonne N. , Patten, Christi A.

Journal of Health Psychology | March 2, 2017 | Volume: 24 | Issue: 12 | Pages: 1710-1723

10.1177/1359105317695878 | PMID 28810418 Get It

Striking cardiovascular health disparities exist among African-Americans in Minnesota compared to Whites; however, community-based interventions to address cardiovascular disease risk are lacking. This study explored participant perceptions of a culturally tailored, cardiovascular disease prevention program developed using a community-based participatory research process. Research participation perceptions, program benefits, and program satisfaction/acceptability were analyzed using a mixed-methods approach. Overall, acceptability was high. Findings highlight the favorable inclusion of African-Americans (research perception), knowledge gained about healthy lifestyle practices (benefits), and quality of the curriculum/speakers (satisfaction). Community-based participatory research may be useful in fostering the acceptability of behavior change interventions among marginalized African-American communities.
Abstract A71: Tumor HLA Class I expression influences immune cells infiltration in metastatic melanoma tumor microenvironment
Yan, Yiyi, Leontovich, Alexey A. , Flotte, Thomas J. , Gerdes, Michael, Santamaría-Pang, Alberto , Sood, Anup , Desai, Keyur , Zhang, Rong , Ginty, Fiona , Chadwick, Chrystal M. , Markovic, Svetomir N.

Cancer Immunology Research | March 1, 2017 | Volume: 5 | Issue: 3_Supplement | Pages: A71-A71

10.1158/2326-6074.tumimm16-a71 Get It

Abstract The variable clinical success with immune checkpoint inhibitors in the treatment of solid tumors challenges us to further understand the regulatory mechanisms of immune cells infiltration – a critical step of tumor elimination – in a highly heterogenous tumor microenvironment (TME). Systemic analyses of the tumor-immune cell interface and interactions are of particular significance with direct clinical impact. We employed a multiplexed immunofluorescence (MxIF) method, a novel technology that allows in situ quantitative single cell characterization with high order protein multiplexing on whole tumor sections, to elucidate the key components in TME governing the immune cells' composition and function in metastatic melanoma lymph node metastases. Here, we show that the expression of tumor cell Human Leukocyte Antigen 1 (HLA-1) is highly heterogeneous both within the TME and between patients. The level of tumor HLA-1 expression directly correlates with the magnitude of cytotoxic T lymphocytes (CTLs) infiltration in the TME. In addition, decreased tumor HLA-1 expression is associated with accumulation of CD20+ cells at the edge of the tumor as well as an increased population of CD4+FOXP3+ cells. The association between tumor HLA-1 expression and immune cell distribution is highly consistent yet heterogenous across the entire tumor mass. Moreover, using quantitative single cell data, we developed algorithms for computational and spatial modeling of tumor-immune cell interfaces, allowing statistical comparison of cellular interactions in the context of tumor heterogeneity. Spatial analysis demonstrates that tumor HLA-1 expression favors CTL invasion, while lack of tumor HLA-1 expression results in CTL evasion. Furthermore, in a cohort of 166 Stage III melanoma patients, we confirm that CTLs infiltration is only present in regions with high tumor HLA-1 expressions, and that patients with tumors high in both tumor HLA-1 and CTLs have significantly improved progression free survival (PFS) compared with those with tumors low in HLA-1 and/or CTLs. Our study demonstrates that the heterogeneous tumor HLA-1 expression results in various immune cell distribution patterns in the TME, directly contributing to the varied antitumor immunities and ultimately influencing tumor outcomes. As part of the antigen presentation machinery, HLA-1 expression on tumors is necessary for CTLs infiltration and is indispensable for T cell mediated tumor elimination with direct clinical benefits. We also establish a novel platform for visualization and spatial representation of the cellular heterogeneity within the TME, providing data processing and modeling algorithms necessary for understanding the cellular interplay mediating tumor surveillance, which will ultimately improve therapeutic efficacy and clinical outcomes. Citation Format: Yiyi Yan, Alexey Leontovich, Thomas Flotte, Michael Gerdes, Fiona Ginty, Alberto Santamaria-Pang, Anup Sood, Keyur Desai, Chrystal Chadwick, Rong Zhang, Svetomir N. Markovic. Tumor HLA Class I expression influences immune cells infiltration in metastatic melanoma tumor microenvironment. [abstract]. In: Proceedings of the AACR Special Conference on Tumor Immunology and Immunotherapy; 2016 Oct 20-23; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2017;5(3 Suppl):Abstract nr A71.
Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism
Mishra, Vivek Kumar , Subramaniam, Malayannan , Kari, Vijayalakshmi, Pitel, Kevin S., Baumgart, Simon J., Naylor, Ryan M. , Nagarajan, Sankari , Ellenrieder, Volker , Hawse, John R. , Johnsen, Steven A. , Wegwitz, Florian , Johnsen, Steven A

Cancer Research | March 1, 2017 | Volume: 77 | Issue: 9 | Pages: 2387-2400

10.1158/0008-5472.can-16-2589 | PMID 28249899 Get It

Abstract TGFβ–SMAD signaling exerts a contextual effect that suppresses malignant growth early in epithelial tumorigenesis but promotes metastasis at later stages. Longstanding challenges in resolving this functional dichotomy may uncover new strategies to treat advanced carcinomas. The Krüppel-like transcription factor, KLF10, is a pivotal effector of TGFβ/SMAD signaling that mediates antiproliferative effects of TGFβ. In this study, we show how KLF10 opposes the prometastatic effects of TGFβ by limiting its ability to induce epithelial-to-mesenchymal transition (EMT). KLF10 depletion accentuated induction of EMT as assessed by multiple metrics. KLF10 occupied GC-rich sequences in the promoter region of the EMT-promoting transcription factor SLUG/SNAI2, repressing its transcription by recruiting HDAC1 and licensing the removal of activating histone acetylation marks. In clinical specimens of lung adenocarcinoma, low KLF10 expression associated with decreased patient survival, consistent with a pivotal role for KLF10 in distinguishing the antiproliferative versus prometastatic functions of TGFβ. Our results establish that KLF10 functions to suppress TGFβ-induced EMT, establishing a molecular basis for the dichotomy of TGFβ function during tumor progression. Cancer Res; 77(9); 2387–400. ©2017 AACR.
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment
Gomez-Chou, Sobeyda B., Świdnicka‐Siergiejko, Agnieszka , Badi, Niharika , Chavez-Tomar, Myrriah , Bekaii‐Saab, Tanios , Mace, Thomas A. , Schmidt, Carl , Liu, Yan , Deng, Defeng , Hwang, Rosa F. , Zhou, Liran , Moore, Todd T., Leng, Xiaohong , Arlinghaus, Ralph B., Logsdon, Craig D. , Cruz‐Monserrate, Zobeida , Lesinski, Gregory B , Farren, Matthew R. , Chatterjee, Deyali , Wang, Huamin , Bekaii-Saab, Tanios S

Cancer Research | March 1, 2017 | Volume: 77 | Issue: 10 | Pages: 2647-2660

10.1158/0008-5472.can-16-1986 | PMID 28249896 Get It

Abstract Lipocalin-2 (LCN2) promotes malignant development in many cancer types. LCN2 is upregulated in patients with pancreatic ductal adenocarcinoma (PDAC) and in obese individuals, but whether it contributes to PDAC development is unclear. In this study, we investigated the effects of Lcn2 depletion on diet-induced obesity, inflammation, and PDAC development. Mice with acinar cell–specific expression of KrasG12D were crossed with Lcn2-depleted animals and fed isocaloric diets with varying amounts of fat content. Pancreas were collected and analyzed for inflammation, pancreatic intraepithelial neoplasia (PanIN), and PDAC. We also used a syngeneic orthotopic PDAC mouse model to study tumor growth in the presence or absence of Lcn2 expression. In addition, to understand the mechanistic role of how LCN2 could be mediating PDAC, we studied LCN2 and its specific receptor solute carrier family 22 member 17 (SLC22A17) in human pancreatic cancer stellate cells (PSC), key mediators of the PDAC stroma. Depletion of Lcn2 diminished extracellular matrix deposition, immune cell infiltration, PanIN formation, and tumor growth. Notably, it also increased survival in both obesity-driven and syngeneic orthotopic PDAC mouse models. LCN2 modulated the secretion of proinflammatory cytokines in PSC of the PDAC tumor microenvironment, whereas downregulation of LCN2-specific receptor SLC22A17 blocked these effects. Our results reveal how LCN2 acts in the tumor microenvironment links obesity, inflammation, and PDAC development. Cancer Res; 77(10); 2647–60. ©2017 AACR
Pulmonologists’ and Primary Care Physicians’ Responses to an Adult Patient with Asthma Who Inquires about Using Electronic Cigarettes as a Smoking Cessation Tool
Nickels, Andrew S., Jenkins, Sarah M. , Tilburt, Jon C. , Hays, J. Taylor , Warner, David O.

Annals of the American Thoracic Society | March 1, 2017 | Volume: 14 | Issue: 3 | Pages: 466-468

10.1513/annalsats.201610-828le | PMID 28248581 Get It

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora, Gerard , Frye, Mark A. , McDonald, William M. , Turner, Mason S., Schatzberg, Alan F. , Summergrad, Paul , Nemeroff, Charles B. , Mathew, Sanjay J.

JAMA Psychiatry | March 1, 2017 | Volume: 74 | Issue: 4 | Pages: 399

10.1001/jamapsychiatry.2017.0080 | PMID 28249076 Get It

Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome
Watson, R. Scott , Crow, Sheri, Hartman, Mary E. , Lacroix, Jacques, Odetola, Folafoluwa O.

Pediatric Critical Care Medicine | March 1, 2017 | Volume: 18 | Issue: 3 | Pages: S4-S16

10.1097/pcc.0000000000001047 | PMID 28248829 Get It

Objective: To summarize the epidemiology and outcomes of children with multiple organ dysfunction syndrome as part of the Eunice Kennedy Shriver National Institute of Child Health and Human Development multiple organ dysfunction syndrome workshop (March 26–27, 2015). Data Sources: Literature review, research data, and expert opinion. Study Selection: Not applicable. Data Extraction: Moderated by an experienced expert from the field, issues relevant to the epidemiology and outcomes of children with multiple organ dysfunction syndrome were presented, discussed, and debated with a focus on identifying knowledge gaps and research priorities. Data Synthesis: Summary of presentations and discussion supported and supplemented by the relevant literature. Conclusions: A full understanding the epidemiology and outcome of multiple organ dysfunction syndrome in children is limited by inconsistent definitions and populations studied. Nonetheless, pediatric multiple organ dysfunction syndrome is common among PICU patients, occurring in up to 57% depending on the population studied; sepsis remains its leading cause. Pediatric multiple organ dysfunction syndrome leads to considerable short-term morbidity and mortality. Long-term outcomes of multiple organ dysfunction syndrome in children have not been well studied; however, studies of adults and children with other critical illnesses suggest that the risk of long-term adverse sequelae is high. Characterization of the long-term outcomes of pediatric multiple organ dysfunction syndrome is crucial to identify opportunities for improved treatment and recovery strategies that will improve the quality of life of critically ill children and their families. The workshop identified important knowledge gaps and research priorities intended to promote the development of standard definitions and the identification of modifiable factors related to its occurrence and outcome.
Proximal femoral replacement in contemporary revision total hip arthroplasty for severe femoral bone loss
Perry, Kevin I. , Taunton, Michael J. , Hanssen, Arlen D. , Viste, Anthony , Abdel, Matthew P. , Taunton, Michael J

The Bone & Joint Journal | March 1, 2017 | Volume: 99-B | Issue: 3 | Pages: 325-329

10.1302/0301-620x.99b3.bjj-2016-0822.r1 | PMID 28249971 Get It

AimsLoss or absence of proximal femoral bone in revision total hip arthroplasty (THA) remains a significant challenge. While the main indication for the use of proximal femoral replacements (PFRs) is in the treatment of malignant disease, they have a valuable role in revision THA for loosening, fracture and infection in patients with bone loss. Our aim was to determine the clinical outcomes, implant survivorship, and complications of PFRs used in revision THA for indications other than malignancy.Patients and MethodsA retrospective review of 44 patients who underwent revision THA using a PFR between 2000 and 2013 was undertaken. Their mean age was 79 years (53 to 97); 31 (70%) were women. The bone loss was classified as Paprosky IIIB or IV in all patients. The mean follow-up was six years (2 to 12), at which time 22 patients had died and five were lost to follow-up.ResultsThe mean Harris Hip Score improved from 42.8 (25.9 to 82.9) pre-operatively to 68.5 (21.0 to 87.7) post-operatively (p = 0.0009). A total of two PFRs had been revised, one for periprosthetic infection eight years post-operatively and one for aseptic loosening six years post-operatively. The Kaplan-Meier survivorship free of any revision or removal of an implant was 86% at five years and 66% years at ten years. A total of 12 patients (27%) had a complication including six with a dislocation.ConclusionPFRs provide a useful salvage option for patients, particularly the elderly with massive proximal femoral bone loss who require revision THA, with significant clinical improvement. While the survivorship of the implant is good at five years, dislocation continues to be the most common complication. The judicious use of larger femoral heads, dual-mobility constructs, or constrained liners may help to minimise the risk of dislocation. Cite this article: Bone Joint J 2017;99-B:325–9.